MedTrace Logo

Arthrex Eclipse™ Shoulder Prosthesis

NCT01790113 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 303

Last updated 2021-02-03

Study results available
· View outcomes & findings →

Summary

A Prospective, Randomized, Multicenter Study comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder to the Univers™ II Shoulder Prosthesis in patients with a degenerative joint disease.

Conditions

Interventions

DEVICE

Univers™

Control

DEVICE

Eclipse™ Total Shoulder Replacement

Investigational

Sponsors & Collaborators

  • Arthrex, Inc.

    lead INDUSTRY

Principal Investigators

  • Melissa Hirschberg · Arthrex, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-04
Primary Completion
2019-06-07
Completion
2019-06-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01790113 on ClinicalTrials.gov